Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced Thyroiditis

By sjmartinez • September 22, 2023

Chen DH, Lenz HJ, Lechner MG, Angell TE. Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor-Induced Thyroiditis. AACE Clin Case Rep. 2023 Jun 3;9(5):162-165. doi: 10.1016/j.aace.2023.05.009. PMID: 37736314; PMCID: PMC10509378.

Tags: efficacy, Endocrinology, immune checkpoint inhibitors, immune-related adverse events, papillary thyroid carcinoma, Publications, thyroiditis

Emerging approaches to male contraception

Yan W, Amory JK. Emerging approaches to male contraception. Andrology. 2024 May 8. doi: 10.1111/andr.13652. Epub ahead of print. PMID: 38716676.

New Insights into IGF-1 Signaling in the Heart

Lee WS, Abel ED, Kim J. New Insights into IGF-1 Signaling in the Heart. Physiology (Bethesda). 2024 May 7. doi: 10.1152/physiol.00003.2024. Epub ahead of print.[...]

Metabolic liability for weight gain in early adulthood

Murthy VL, Mosley JD, Perry AS, Jacobs DR Jr, Tanriverdi K, Zhao S, Sawicki KT, Carnethon M, Wilkins JT, Nayor M, Das S, Abel ED,[...]